Coronavirus: Hungary To Produce Favipiravir Drug Within Months

  • 13 May 2020 11:23 AM
  • Hungary Matters
Coronavirus: Hungary To Produce Favipiravir Drug Within Months
Hungarian researchers have concluded the first phase of developing favipiravir, a medication proven effective against cases of the novel coronavirus in Asia.

Production of the drug might start as early as this autumn, the innovation and technology ministry said.

The infrastructure for clinical tests and manufacturing will be provided by a wide-ranging cooperation between the government, research institutes, universities and companies, the ministry said.

The government is funding the work with a 370 million forint (EUR 1.1m) grant, State Secretary Tamás Schanda said.

Favipiravir is used to alleviate flu symptoms. Clinical tests are yet to be conducted, and so it is not registered as a medicine in Europe and the US.

Favipiravir has shown results in patients with Covid-19, the ministry said.

Related links

Japan To Provide Coronavirus Medicine, Says Hungarian FM Szijjártó

  • How does this content make you feel?

XpatLoop Media Partner

Hungary Matters

Launched in January 2014, this twice-daily newsletter covers 'everything you need to know about what’s going on in Hungary and beyond', according to its publisher the state media agency MTI. Click the title above for more info, and to subscribe.

Explore More Reports